The U.S. Food and Drug Administration has designated SetPoint Medical’s neurostimulator a breakthrough device for the treatment of relapsing-remitting multiple sclerosis (RRMS).
This designation is intended to accelerate the development of devices intending to more effectively treat or diagnose life-threatening or chronically debilitating diseases than standard approaches.
It was supported by evidence showing that SetPoint’s nerve stimulator platform may slow myelin damage and promote its repair, an unmeet need in multiple sclerosis (MS) and other demyelinating conditions. The company now is planing to work with the regulatory agency to open a clinical trial of the therapeutic device in RRMS patients.
https://multiplesclerosisnewstoday.com/ ... WToJ2giAHz
Neurostimulator to repair myelin in RRMS
-
- Similar Topics
- Replies
- Views
- Last post
-
- 6 Replies
- 1898 Views
-
Last post by NHE
-
- 1 Replies
- 1874 Views
-
Last post by val57gal
-
- 0 Replies
- 1794 Views
-
Last post by NHE
-
- 0 Replies
- 2326 Views
-
Last post by DIM
-
- 2 Replies
- 1732 Views
-
Last post by jimmylegs
-
- 40 Replies
- 8027 Views
-
Last post by ElliotB
-
- 0 Replies
- 1826 Views
-
Last post by frodo
-
- 3 Replies
- 1166 Views
-
Last post by Scott1